Rituximab as induction therapy in eosinophilic granulomatosis with polyangiitis refractory to conventional immunosuppressive treatment: A 36-month follow-up analysis
The Journal of Allergy and Clinical Immunology: In Practice | Sep 20, 2017
The Journal of Allergy and Clinical Immunology: In Practice | Sep 20, 2017